Hamps Bio IPO
GMP, Subscription, Price, Dates & Financial Details
Hamps Bio Limited is a company engaged in the ethical marketing and distribution of pharmaceutical products and the manufacturing of freeze-dried and frozen food products. The company operates under two main divisions: the Pharmaceutical Products Division (Pharma) and the Freeze Dried and Frozen…
Open Date
Fri, 13 Dec 2024
Close Date
Tue, 17 Dec 2024
Issue Price
₹ 51
Lot Size
2000
Issue Size
₹ 6.22 Cr
Minimum Investment
₹ 204,000 (4000 Shares)
Grey Market Premium Analysis
Day Wise GMP→Unofficial premium quoted in the grey market, tracked daily against the price band cap.
Grey market trading is unregulated. GMP figures are indicative only and should not be the sole basis for investment decisions - treat as a sentiment indicator, not a guarantee.
IPO Details
Hamps Bio IPO has successfully completed its IPO process and is now listed on BSE SME Platform. According to the Red Herring Prospectus (RHP), the IPO was a fixed price issue with a total issue size of ₹6.22 Crore, comprising a fresh issue of 12.20 Lakh equity shares aggregating to ₹6.22 Crore.
The Hamps Bio IPO remained open for subscription from December 13, 2024, to December 17, 2024. The basis of allotment was finalized on December 18, 2024, and the company's shares were listed on BSE SME Platform on December 20, 2024.
The company had fixed the price at ₹51 per share, with a lot size of 2000 shares. Retail investors were required to make a minimum investment of ₹204,000 (based on the upper price band) to apply for one lot.
Bigshare Services Pvt Ltd served as the registrar to the issue. MARWADI CHANDARANA INTERMEDIARIES BROKERS PRIVATE LIMITED acted as the Book Running Lead Managers (BRLMs) to the issue.
With the successful completion of the IPO process, Hamps Bio Limited is now a publicly listed company on BSE SME Platform. Investors can track the company's share price, trading performance, financial results, and corporate announcements through the stock exchanges.
Hamps Bio IPO Timeline (Tentative)
- IPO Open Date
- Fri, 13 Dec 24
- IPO Close Date
- Tue, 17 Dec 24
- Basis of Allotment
- Wed, 18 Dec 24
- Initiation of Refunds
- Thu, 19 Dec 24
- Credit of Shares to Demat
- Thu, 19 Dec 24
- Listing Date
- Fri, 20 Dec 24 — NSE & BSE
Open Date
13 December 2024
Close Date
17 December 2024
Basis Of Allotment
18 December 2024
Listing Date
20 December 2024
IPO Subscription
Check Live Subscription →The Hamps Bio IPO has received bids for 1,22,40,74,000 shares against 11,58,000 shares offered, resulting in an overall subscription of 1,057.06x. the NII category is subscribed 758.37x, Retail Investors 1,342.04x, and QIBs 0x.
QIB
0x
NII
758.37x
RII
1342.04x
Total
1057.06x
IPO Reservations
The Retail Individual Investor (RII) category has the highest allocation with 5,79,000 shares, representing 47.46% of the total issue. Qualified Institutional Buyers (QIBs) are allocated 0 shares (%), while Non-Institutional Investors (NIIs) receive 5,79,000 shares (47.46%).
| Category | Shares Offered | Shares Offered % |
|---|---|---|
| Market Maker | 62,000 | 5.08% |
| Non-Institutional | 579,000 | 47.46% |
| Retail Investors | 579,000 | 47.46% |
| Total | 1,220,000 | 100% |
Financials Details(₹ in Crores)
| Particular | 31 Oct 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets | 644 | 514.77 | 395.87 | 364.31 |
| Revenue | 436.42 | 650.13 | 558.49 | 534.46 |
| Profit After Tax | 34.08 | 50.07 | 35.9 | 12.15 |
| Net Worth | 370.78 | 337.42 | 136.3 | 100.57 |
| Reserve & Surplus | 57.18 | 141.42 | -13.7 | -49.43 |
| Total Borrowings | 138.31 | 104.52 | 173.77 | 204.31 |
Financials Performance
Performance Indicators
EPS Pre
Earnings per share before the IPO.
P/E Pre
IPO Offer Price ÷ EPS Pre.
EPS Post
Expected earnings per share after the IPO..
P/E (Post Issue)
IPO Offer Price ÷ EPS Post.
Hamps Bio Limited KPI Information
| Particular | KPI as of March 31, 2024. |
|---|---|
| ROE % | 21.14 |
| ROCE % | 18.31 |
| Debt / Equity | 0.31 |
| RoNW % | 14.84 |
| PbW | 2.96 |
| Pat Margin % | 7.73 |
Peers Comparison
No Peer Comparision Available
About Hamps Bio Limited
Hamps Bio Limited is a company engaged in the ethical marketing and distribution of pharmaceutical products and the manufacturing of freeze-dried and frozen food products. The company operates under two main divisions: the Pharmaceutical Products Division (Pharma) and the Freeze Dried and Frozen Products (FDFP or FMCG) Division.
Pharmaceutical Products Division
Founded in 2007, Hamps Bio started as an ethical pharmaceutical marketing firm in Gujarat, distributing a variety of pharmaceutical products. These products, such as tablets, syrups, capsules, injectables, and powders, cover a range of therapeutic areas including pediatric care, painkillers, antibiotics, and nutrition supplements. The products are marketed under the brand name “Hamps” and sourced from 16 WHO GMP certified contract manufacturers. The company operates a systematic distribution model, utilizing a network of over 50 distributors and a marketing team that serves approximately 8,000 doctors and medical stores each month, facilitating the sale of 60,000 units. Its main focus is on the domestic market in India, particularly targeting doctors in specialties such as orthopedics, gynecology, dermatology, and surgery.
Freeze Dried and Frozen Products Division (FDFP)
Launched in 2017, this division focuses on the manufacturing of freeze-dried and frozen products, including fruits, vegetables, herbs, and flowers. These products are processed using lyophilization (freeze-drying) technology and are sold both under the brand “FzyEzy” and through contract manufacturing. Hamps Bio’s FDFP products cater to both B2B and B2C business models, supplying industries such as flavor tea, soups, nutrition bars, chocolates, and ice cream, as well as being sold directly to consumers via e-commerce platforms like Amazon and Flipkart. The manufacturing facility in Gujarat is equipped with modern technology and certified with ISO 9001:2015, ISO 22000:2018, FSSAI, and U.S. FDA accreditations.
Hamps Bio has an extensive distribution network, selling its products across 8 Indian states for pharmaceuticals and in 6 countries and 22 states for its freeze-dried food products. The company’s focus on quality control and innovation has allowed it to expand both domestically and internationally.
Hamps Bio IPO Promoters
- Herrik Shah
- Shrenik Shah
- Pallavi Shah
- Mitali Shah
- Herrik Shah HUF
- Shrenik Shah HUF
Promoters Holding
Holding Pre Issue
100.00%
Holding Post Issue
71.99%
Hamps Bio IPO Objective
The Company intends to use its proceeds as follows:
- Purchase of plant & machinery for FMCG division
- Enhancing the visibility and awareness of the brand
- General corporate purposes
Hamps Bio Limited Address / Contact Details
Hamps Bio Limited
2900/112, GIDC, Near
Atul Limited, Ankelshwar
Bharuch – 393 002
Gujarat
Phone: +91 8000006663
Email: info@hampsbio.com
Website: http://www.hampsbio.com
IPO Snapshot
Hamps Bio IPO Lot Size
The Hamps Bio IPO has a lot size of 2,000 shares. Retail investors require a minimum investment of ₹1,02,000 by applying for 1 lot (2,000 shares). The maximum application allowed for the retail category is 1 lots (2,000 shares), requiring an investment of ₹1,02,000.
| Application | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 2,000 | 102,000.00 |
| Retail (Max) | 1 | 2,000 | 102,000.00 |
| S-HNI (Min) | 2 | 4,000 | 204,000.00 |
Issue Reservation
- Market Maker — 5.08%
- NII — 47.46%
- RII — 47.46%
Book Running Lead Managers
- MARWADI CHANDARANA INTERMEDIARIES BROKERS PRIVATE LIMITED
IPO Documents & Links
Explore More IPOs
Currently Open
Coming Up Next
Disclaimer: This data is for informational purposes only and does not constitute investment advice.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
What is the Hamps Bio IPO?
Hamps Bio IPO is a Fixed price IPO with a total issue size of ₹6.22 crore. The Hamps Bio IPO price band is ₹51 to 51 per share. The Hamps Bio IPO subscription opens on Fri, Dec 13, 2024, and closes on Tue, Dec 17, 2024. The Hamps Bio IPO will be listed on the BSE. Bigshare Services Pvt Ltd is the registrar for the Hamps Bio IPO.
When will the Hamps Bio IPO open for subscription?
The Hamps Bio IPO opens on Fri, Dec 13, 2024 and closes on Tue, Dec 17, 2024
What is Hamps Bio IPO Price Band?
Hamps Bio IPO Price Band is ₹51 to 51 per share.
What is Hamps Bio IPO Lot Size?
Hamps Bio IPO lot size is 2000 shares, Retail investors need a minimum investment of ₹204000 based on the upper price band
What is the minimum investment for Hamps Bio IPO?
The minimum investment for Hamps Bio IPO is ₹204000, based on one lot of 2000 shares at the upper price band of ₹51 per share.
How to apply for Hamps Bio IPO?
Investors can apply for the Hamps Bio IPO through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or through UPI using a SEBI-registered broker or trading app. Select the desired lot size, enter your bid within the price band, and submit the application before Tue, Dec 17, 2024. The application amount remains blocked until the Hamps Bio IPO allotment is finalized.
What is Hamps Bio IPO Issue Size?
Hamps Bio IPO issue size is ₹6.22 crores.
What is the Hamps Bio IPO Allotment Date?
Hamps Bio IPO allotment date is Wed, Dec 18, 2024.
Who is the Hamps Bio IPO Registrar?
The registrar for Hamps Bio IPO is Bigshare Services Pvt Ltd. Investors can go to Bigshare Services Pvt Ltd website to check Hamps Bio IPO allotment status, refund processing, and other IPO-related information.
What is the Hamps Bio IPO GMP?
The Hamps Bio IPO GMP (Grey Market Premium) is ₹60 as of Fri, Dec 20, 2024. Based on the upper price band of ₹51 per share, the estimated Hamps Bio IPO listing price is ₹111, indicating a potential listing gain of approximately 117.65% over the issue price.
Who is the Hamps Bio IPO Lead Manager?
The book-running lead managers (BRLMs) for the Hamps Bio IPO are MARWADI CHANDARANA INTERMEDIARIES BROKERS PRIVATE LIMITED. The lead managers are responsible for managing the IPO process, including issue structuring, regulatory compliance, marketing the public issue, coordinating with investors, and ensuring a smooth listing process. For complete details, investors should refer to the Hamps Bio IPO Red Herring Prospectus (RHP).